Longer-term outcome data from SYNTAX trial give a 'clear mandate' to expand the role of CABG and to adopt a more cautious indication for PCI in multivessel disease, one expert says.

The beneficial effect on all-cause mortality of coronary artery bypass grafting surgery (CABG) observed at 4 and 5 years in women with complex coronary disease seen in the SYNTAX trial is gone at ...

For the SYNTAXES study, which will also be presented at the upcoming virtual European Society of Cardiology Congress, Serruys, Hironori Hara, MD (University of Amsterdam, the Netherlands), and ...

SAN DIEGO, CA—Long-term follow-up from two new studies—MAIN-COMPARE and SYNTAX Extended Survival (SYNTAXES)—provide new insights into the relative strengths and weaknesses of PCI and CABG for the ...

SAN DIEGO — In preliminary 10-year results of the SYNTAXES study presented at TCT 2018, there was no significant difference in survival between patients who had CABG and those who had PCI with a ...